Literature DB >> 23949293

Human papillomavirus detection in Moroccan patients with bladder cancer.

Noâma Berrada1, Abderrahmane Al-Bouzidi, Ahmed Ameur, Mohammed Abbar, Mohammed El-Mzibri, Rabii Ameziane-El-Hassani, Laïla Benbacer, Meriem Khyatti, Zineb Qmichou, Saaïd Amzazi, Mohammed Attaleb.   

Abstract

INTRODUCTION: Human papillomavirus (HPV) is associated with more human cancers than any other virus. Many studies have investigated the association between bladder cancer and HPV but the results remain controversial. The aim of the present study is to evaluate whether HPV have an etiological role in bladder carcinogenesis among Moroccan patients.
METHODOLOGY: Forty-eight fresh biopsies (43 bladder tumors and 5 non-tumor samples) were collected for this purpose. Nested PCR with the consensus MY09/MY11 and GP5+/GP6+ primers was performed to detect the presence of HPV L1 gene DNA.
RESULTS: The results showed that 52.4% of bladder cancer patients were positive for HPV. Subsequent DNA sequencing of positive cases of HPV revealed the presence of HPV16 in 95.5% of bladder tumor samples. The occurrence of HPV infection varies according to clinicopathological features, but there is no significant correlation between the viral infection and tumor stage or grade. In addition, statistical analysis demonstrated that there is no association between age or sex and HPV infection.
CONCLUSION: Our data indicate for the first time that bladder tumors from Moroccan patients harbor HR-HPV genotypes, especially HPV16, and thereby suggest that this virus may play a causative role in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949293     DOI: 10.3855/jidc.3068

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.

Authors:  Jisu Lee; Hyungtaek Jeon; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  Tumour Biol       Date:  2015-09-21

2.  Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.

Authors:  Sebastian C Schmid; Leonore Thümer; Tibor Schuster; Thomas Horn; Florian Kurtz; Julia Slotta-Huspenina; Judith Seebach; Michael Straub; Tobias Maurer; Michael Autenrieth; Hubert Kübler; Margitta Retz; Ulrike Protzer; Jürgen E Gschwend; Dieter Hoffmann
Journal:  Infect Agent Cancer       Date:  2015-09-21       Impact factor: 2.965

3.  Expression and prognostic value of SULT1A2 in bladder cancer.

Authors:  Yinghui Chao; Qifeng Ou; Jin Shang
Journal:  Exp Ther Med       Date:  2021-05-19       Impact factor: 2.447

Review 4.  Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.

Authors:  Narcisa Muresu; Biagio Di Lorenzo; Laura Saderi; Illari Sechi; Arcadia Del Rio; Andrea Piana; Giovanni Sotgiu
Journal:  Diagnostics (Basel)       Date:  2022-07-20

5.  Human Papillomavirus in Urothelial Carcinoma of Bladder: An Indian study.

Authors:  Uttam K Mete; Sunil Shenvi; Mini P Singh; Anuradha Chakraborti; Nandita Kakkar; Radha Kanta Ratho; Arup K Mandal
Journal:  Int J Appl Basic Med Res       Date:  2018 Oct-Dec

6.  Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.

Authors:  Alireza Khatami; Zahra Salavatiha; Mohammad Hossein Razizadeh
Journal:  Infect Agent Cancer       Date:  2022-01-21       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.